[Gastroesophageal reflux disease in 2024].
Meddy DalexAlain M SchoepferJeanine Wakim El-KhouryPublished in: Revue medicale suisse (2024)
Gastroesophageal reflux disease is the most frequent gastroente-rological diagnosis, with a high prevalence of symptoms impacting patients' quality of life and causing high economic costs. It has a -complex pathophysiology that encompasses different mechanisms and an overlap with functional disorders that cause similar symptoms. Hence, an accurate diagnosis and phenotyping of patients is crucial to individualize therapy and limit health costs. Nowadays, therapy is personalized and encompasses lifestyle interventions, proton pump inhibitors, surgery, neuromodulation, diaphragmatic breathing as well as, in the future, new drugs and endoscopic interventions.
Keyphrases
- end stage renal disease
- newly diagnosed
- gastroesophageal reflux disease
- ejection fraction
- chronic kidney disease
- physical activity
- healthcare
- prognostic factors
- cardiovascular disease
- type diabetes
- minimally invasive
- high throughput
- sleep quality
- patient reported outcomes
- coronary artery disease
- mass spectrometry
- weight loss
- cell therapy
- atrial fibrillation
- single cell
- replacement therapy
- endoscopic submucosal dissection